HomeACADEMIA
ACADEMIA

Japan Gastric Cancer Association to Wait for Opdivo Nod before Guidelines Update, Keytruda Won’t Make It This Time
(Aug.16.2017)

The Japanese Gastric Cancer Association (JGCA) will wait for gastric cancer approval of Ono Pharmaceutical’s anti-PD-1 antibody Opdivo (nivolumab) in order to list the drug on an updated version of its gastric cancer treatment guidelines, according to people familiar with the matter ...
(LOG IN FOR FULL STORY)

News Calendar